Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5196334
Max Phase: Preclinical
Molecular Formula: C13H13BrO3
Molecular Weight: 297.15
Associated Items:
ID: ALA5196334
Max Phase: Preclinical
Molecular Formula: C13H13BrO3
Molecular Weight: 297.15
Associated Items:
Canonical SMILES: O=C(O)/C=C1\CCCc2ccc(Br)cc2C1O
Standard InChI: InChI=1S/C13H13BrO3/c14-10-5-4-8-2-1-3-9(6-12(15)16)13(17)11(8)7-10/h4-7,13,17H,1-3H2,(H,15,16)/b9-6+
Standard InChI Key: HTAMAYUCMQUSJV-RMKNXTFCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 297.15 | Molecular Weight (Monoisotopic): 296.0048 | AlogP: 2.83 | #Rotatable Bonds: 1 |
Polar Surface Area: 57.53 | Molecular Species: ACID | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.52 | CX Basic pKa: | CX LogP: 2.93 | CX LogD: -0.44 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.62 | Np Likeness Score: 0.36 |
1. Tian Y, Shehata MA, Gauger SJ, Veronesi C, Hamborg L, Thiesen L, Bruus-Jensen J, Royssen JS, Leurs U, Larsen ASG, Krall J, Solbak SMØ, Wellendorph P, Frølund B.. (2022) Exploring the NCS-382 Scaffold for CaMKIIα Modulation: Synthesis, Biochemical Pharmacology, and Biophysical Characterization of Ph-HTBA as a Novel High-Affinity Brain-Penetrant Stabilizer of the CaMKIIα Hub Domain., 65 (22.0): [PMID:36346645] [10.1021/acs.jmedchem.2c00805] |
Source(1):